Literature DB >> 1019146

Individual variability in response to haloperidol.

A O Forsman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1019146      PMCID: PMC1863621     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  5 in total

1.  INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY.

Authors:  H KUTT; M WOLK; R SCHERMAN; F MCDOWELL
Journal:  Neurology       Date:  1964-06       Impact factor: 9.910

2.  A gas chromatographic method for determining haloperidol. A sensitive procedure for studying serum concentration and pharmacokinetics of haloperidol in patients.

Authors:  A Forsman; E Mårtensson; G Nyberg; R Ohman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

3.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

4.  Pharmacological and clinical problems of lithium prophylaxis.

Authors:  M Schou; P C Baastrup; P Grof; P Weis; J Angst
Journal:  Br J Psychiatry       Date:  1970-06       Impact factor: 9.319

5.  Influence of first-pass effect on availability of drugs on oral administration.

Authors:  M Gibaldi; R N Boyes; S Feldman
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

  5 in total
  5 in total

1.  High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin.

Authors:  N Bjørndal; M Bjerre; J Gerlach; P Kristjansen; G Magelund; I H Oestrich; J Waehrens
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

2.  Comparison of dexamethasone with ondansetron or haloperidol for prevention of patient-controlled analgesia-related postoperative nausea and vomiting: a randomized clinical trial.

Authors:  Po-Kai Wang; Pei-Jiuan Tsay; Chia-Chun Huang; Hsien-Yong Lai; Pei-Chin Lin; Shen-Jer Huang; Yi Lee
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

3.  Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment.

Authors:  L B Hansen; N E Larsen
Journal:  Psychopharmacology (Berl)       Date:  1977-07-18       Impact factor: 4.530

4.  Haloperidol dose combined with dexamethasone for PONV prophylaxis in high-risk patients undergoing gynecological laparoscopic surgery: a prospective, randomized, double-blind, dose-response and placebo-controlled study.

Authors:  Jin Joo; Yong Gyu Park; Jungwon Baek; Young Eun Moon
Journal:  BMC Anesthesiol       Date:  2015-07-08       Impact factor: 2.217

5.  Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation.

Authors:  Mohd Yasir; Udai Vir Singh Sara
Journal:  Acta Pharm Sin B       Date:  2014-11-21       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.